1. Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc. (1st January 2022) Authors: Rose, Ronald; Gartland, Margaret; Li, Zhufang; Zhou, Nannan; Cockett, Mark; Beloor, Jagadish; Lataillade, Max; Ackerman, Peter; Krystal, Mark Journal: AIDS Issue: Volume 36:Number 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc. (1st January 2022) Authors: Rose, Ronald; Gartland, Margaret; Li, Zhufang; Zhou, Nannan; Cockett, Mark; Beloor, Jagadish; Lataillade, Max; Ackerman, Peter; Krystal, Mark Journal: AIDS Issue: Volume 36:Number 1(2022) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗